Simultaneous confidence intervals to compare gene expression profiles using ABC transporter TaqMan microfluidic cards

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 853-860

  Pizzamiglio, Sara ^a   Cossa, Giacomo ^a   Gatti, Laura ^a   Beretta, Giovanni L ^a   Corna, Elisabetta ^a   Tinelli, Stella ^a   Verderio, Paolo ^a   Perego, Paola ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

ABC transporters; Microfluidic cards; Ovarian carcinoma; Simultaneous confidence intervals

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G1; ABCC6; CAMPTOTHECIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GIMATECAN; MELPHALAN; MITOXANTRONE; PACLITAXEL; TOPOTECAN; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN CELL; MICROFLUIDICS; MULTIDRUG RESISTANCE; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 77349116582     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000707     Document Type: Article

References (30)

1. Martin LP and Schilder RJ: Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol 36: 112-125, 2009.
2. Pizzolato JF and Saltz L: The camptothecins. Lancet 361: 2235-2242, 2003.
3. Rasheed ZA and Rubin EH: Mechanisms of resistance to topoisomerase I-targeting drugs. Oncogene 22: 7296-7304, 2003.
4. Cossa G, Gatti L, Zunino F and Perego P: Strategies to improve the efficacy of platinum compounds. Curr Med Chem 16: 2355-2365, 2009.
5. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
6. Borst P, Evers R, Kool M and Wijnholds J: A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 921: 1295-1302, 2000.
7. Chin L and Gray JW: Translating insights from the cancer genome into clinical practice. Nature 452: 553-563, 2008.
8. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T). Methods 25: 402-408, 2001.
9. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC and Zunino: Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 56: 556-562, 1996.
10. Perego P, Beretta GL and Gatti L: Identification of determinants of sensitivity to antitumor drugs. In: Handbook of Proteomic Methods. Conn PM (ed). Human Press, Totowa, NJ, pp319-330, 2003.
11. Perego P, Romanelli S, Carenini N, Magnani I, Leone R, Bonetti A, Paolicchi A and Zunino F: Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to taxol. Ann Oncol 9: 1-8, 1998.
12. Dixon WJ: Ratios involving extreme values. Ann Math Stat 22: 68-78, 1951.
13. Efron B and Tibshirani RJ: An introduction to the bootstrap. Chapman and Hall, Inc., New York, 1993.
14. Mandel M and Betensky RA: Simultaneous confidence intervals based on the percentile bootstrap approach. Comput Stat Data Anal 52: 2158-2165, 2008.
15. SAS Institute, Inc., 1999. SAS OnlineDoc®, Version 8. SAS Institute, Inc., Cary, NC.
16. Benedetti V, Perego P, Beretta GL, Corna E, Tinelli S, Righetti SC, Leone R, Apostoli P, Lanzi C and Zunino: Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds. Mol Cancer Ther 7: 679-687, 2008.
17. Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J and Cottrill H: Genomic signatures to guide the use of chemotherapeutics. Nat Med 12: 1294-1300, 2006.
18. Hood L, Heath JR, Phelps ME and Lin B: Systems biology and new technologies enable predictive and preventive medicine. Science 306: 640-543, 2004.
19. Demissie M, Mascialino B, Calza S and Pawitan Y: Unequal group variances in microarray data analysis. Bioinformatics 24: 1168-1174, 2008.
20. Nies AT and Keppler D: The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 453: 643-659, 2007.
21. Bergen AA, Plomp AS, Hu X, de Jong PT and Gorgels TG: ABCC6 and pseudoxanthoma elasticum. Pflugers Arch 453: 685-691, 2007.
22. Velamakanni S, Wie SL, Janvilisri T and van Veen HW: ABCG transporters: structure, substrate specificities and physiological roles: a brief overview. J Bioenerg Biomembr 39: 465-471, 2007.
23. Yu LR, Zhu Z, Chan KC, Issaq HJ, Dimitrov DS and Veenstra TD: Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res 6: 4150-4162, 2007.
24. Wenzel JJ, Piehler A and Kaminski WE: ABC A-subclass proteins: gatekeepers of cellular phospho- and sphingolipid transport. Front Biosci 12: 3177-3193, 2007.
25. Kimura Y, Morita SY, Matsuo M and Ueda K: Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci 98: 1303-1310, 2007.
26. Zelcer N, Saeki T, Reid G, Beijnen JH and Borst P: Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem 276: 46400-46407, 2001.
27. Marchetti S, Oostendorp RL, Pluim D, van Eijndhoven M, van Tellingen O, Schinkel AH, Versace R, Beijnen JH, Mazzanti R and Schellens JH: In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2. Mol Cancer Ther 6: 3307-3313, 2007.
28. Gounder MK, Nazar AS, Saleem A, Pungaliya P, Kulkarni D, Versace R and Rubin EH: Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan. Invest New Drugs 26: 205-213, 2008.
29. Iwamori M, Iwamori Y, Kubushiro K, Ishiwata I and Kiguchi K: Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. J Biochem 141: 309-317, 2007.
30. Gatti L, Beretta GL, Cossa G, Zunino F and Perego P: ABC transporters as potential targets for modulation of drug resistance. Mini Rev Med Chem 9: 1102-1112, 2009.